Glenmark receives USFDA’s tentative approval for anti-coagulant drug
The US health regulator has provided its tentative approval to Glenmark Pharmaceuticals for anti-coagulant medication Dabigatran Etexilate capsules. Glenmark has said in a BSE filing...